- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 324
Oxford experiments with Lab10x
Lab10x will accelerate the commercialisation of digital therapeutics and data-driven drug discovery, and is being launched in partnership with Sensyne Health and Evotec.
Jun 24, 2019Corporate venturing deal net: 17-21 June 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Jun 21, 2019Daily deal net: June 21, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jun 21, 2019Vienna pair press with P4 Therapeutics
Building on joint research from University of Vienna and Medical University of Vienna, P4 is creating next-generation platinum chemotherapy with fewer side-effects than current approaches.
Jun 21, 2019Caixa Capital’s Vazquez veers to Next47
Adiari Vazquez, formerly investment manager at Caixa Geral de Depósitos’ Caixa Capital subsidiary, has joined Siemens-backed Next47 as an associate.
Jun 21, 2019Arteac-Lab experiments with Simbox licence
Satt Sud-Est has assigned an exclusive licence to Arteac-Lab, co-founded by former CNRS researcher Philippe Herzog, for an electroacoustic modeling software called Simbox.
Jun 21, 2019Daily deal net: June 20, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jun 20, 2019Niantic picks up Sensible Object
The mobile game studio has acquired interactive tabletop game maker Sensible Object, handing exits to Amazon and NCSoft.
Jun 20, 2019BioSerenity eases its way to series B stage
Dassault Systèmes has led a $56.5m series B round for health monitor developer BioSerenity, which also welcomed back return investors Idinvest Partners, LBO France and BPIfrance.
Jun 20, 2019Imperial and TUM band together for fund
A collaborative research fund established by Imperial and TUM has made its public debut with at least 12 projects in its portfolio focused on areas including healthcare, energy and industry.
Jun 20, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


